P&G Health Share Price: Revenue bhaga **20.7%**, par profit gira **14.6%**! Kya chal raha hai?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
P&G Health Share Price: Revenue bhaga **20.7%**, par profit gira **14.6%**! Kya chal raha hai?
Overview

So, P&G Health ne Q3 mein revenue toh **20.7%** badha liya, pakda **₹37,386 lakh** ka sales! Lekin bhai, kharcha **40.3%** badh gaya, isliye profit **14.6%** gir gaya, ab aaya **₹7,759 lakh**. Share price pe kya impact hoga?

Achanak profit mein kami? Poora breakdown dekho!

Arre suno, P&G Health ke results aa gaye hain aur yeh kaafi interesting hain! Company ka revenue toh ekdum 20.7% bhaga hai pichhle saal ke comparison mein, pohoch gaya ₹37,386 lakh (yaani ₹373.86 Crore) pe Q3 FY26 mein. Total income bhi 20.5% badh ke ₹37,822 lakh ho gaya.

Lekin yahan ek bada twist hai! Company ka kharcha ekdum se 40.3% badh gaya. Ismein sabse zyada badhotri dikhi raw material mein (37.1% up), employee benefits mein (31.4% up), aur baaki expenses mein (44.4% up). Jab kharche itne badh jaate hain, toh profit pe pressure toh aayega hi!

Is wajah se, Profit Before Tax (PBT) 10.6% kam ho gaya, ₹10,882 lakh pe. Aur Net Profit ki baat karein toh yeh 14.6% gir kar ₹7,759 lakh (yaani ₹77.59 Crore) pe aa gaya. Pichhle saal isi quarter mein yeh ₹9,090 lakh tha. Earnings Per Share (EPS) bhi pehle ke ₹54.76 se ghata kar ₹46.74 ho gaya hai.

9 Mahine ka Performance

Ab agar saal ke pehle 9 mahine ki baat karein, toh revenue mein 14.4% ki badhotri dikhi hai, jo ₹1,03,752 lakh (yaani ₹1,037.52 Crore) ho gaya. Aur net profit bhi 22.3% badh kar ₹23,231 lakh (yaani ₹232.31 Crore) ho gaya. Par ek cheez note karna zaroori hai ki pichhle saal ke 9 mahine mein ek ₹2,019 lakh ka exceptional item tha, jiske na hone ki wajah se yeh growth numbers aur bhi acche lag rahe hain.

Dividend ka Dhamaka!

Aur haan, investors ke liye ek khush khabri hai! Board of Directors ne FY2025-26 ke liye ₹160 per equity share ka interim dividend declare kiya hai. Ismein ₹50 ka special dividend bhi included hai! Yeh investors ko March 4, 2026 tak mil jayega.

Aage Kya?

Jo sabse badi chinta hai woh hai Q3 mein expenses ki wajah se profit margin ka kam hona. Revenue toh acha chal raha hai, par company ko ab yeh dekhna hoga ki woh apne badhte kharchon ko kaise control karte hain taaki profit margin safe rahe. Dekhte hain aage company kya strategy lati hai.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.